Profile
David John King is the founder of Lassen Therapeutics 1, Inc. He worked as the Chief Scientific Officer at aTyr Pharma, Inc. in 2018 and at AnaptysBio, Inc. from 2011 to 2016.
Prior to that, he held director and senior director positions in molecular biology and biochemistry at Medarex, Inc., Coulter Pharmaceuticals, Inc., and Corixa Corp.
He was also a scientist at Celltech Ltd.
and a Senior Vice President of Research at Tunitas Therapeutics, Inc. Dr. King received his undergraduate degree from the University of Warwick and his doctorate from the University of Surrey.
Former positions of David John King
| Companies | Position | End |
|---|---|---|
| ATYR PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2018-12-30 |
Tunitas Therapeutics, Inc.
 Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2016-08-31 |
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | 2016-01-31 |
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Founder | - |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | - |
Training of David John King
| University of Warwick | Undergraduate Degree |
| University of Surrey | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- David John King
